RAP-103 is an orally active CCR antagonist that provides potent synaptic protection by inhibiting and reversing cytoskeletal changes induced by PrPC/NOX signaling. RAP-103 is potentially useful in Alzheimers disease (AD) research[1].
Molecular Weight:
598.60
CAS Number:
[1337998-99-8]
Formula:
C25H38N6O11
Target:
CCR
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted